Zydus Cadila receives USFDA approval to market generic cance

The company has received final approval from the US Food and Drug Administration (USFDA) to market Decitabine for Injection in the strength of 50 mg/vial single-dose vial.

Related Keywords

United States , American , Zydus Cadila , Drug Administration , Zydus Cadila News , Usfda , Cancer Treatment Drug , Generic Cancer Drug , Ydus Cadila Generic Cancer Drug , Decitabine ,